The IMI-funded project Ensuring the Future Of EUPATI (2018-2020) aimed to ensure optimal exploitation and sustainability of the core achievements of the IMI-EUPATI Project (2012-2017): Patient Expert Training Course, the multilingual public Toolbox, and the EUPATI National Platforms Network.


    • Develop a viable sustainability / business model for the medium-long term future of EUPATI activities.
    • Create a Patient Education and Engagement Portal that will host relevant information and resources for patients and other stakeholders to ensure meaningful and value adding patient engagement in medicines R&D. This will replace the existing EUPATI website.
    • Strength the coordination and impact of the existing EUPATI National Platform (ENP) network, through promotion of collaboration, knowledge exchange and sharing.

The IMI-EFOEUPATI project was launched on 1 September 2018 and ran for 24 months, until August 2020. The project was co-lead by the European Patients’ Forum (EPF) and Bayer.



This project received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806995. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.